Alzheimer’s Blood Test Identifies Cognitive Impairment with High Accuracy
New research finds that the PrecivityAD2 blood test can identify brain amyloid status with values that approximate those of PET imaging.
New research finds that the PrecivityAD2 blood test can identify brain amyloid status with values that approximate those of PET imaging.
The Florida Health Department will use DiaCarta's RadTox test for early detection of cancer treatment response and resistance.
While being treated for an enlarged prostate, Britain’s King Charles III was diagnosed with an undisclosed form of cancer.
A new algorithm may help identify high-risk precancerous lesions on the fallopian tubes thought to lead to a common form of ovarian cancer
Researchers developed a rapid, accurate test for diagnosing malaria that is significantly faster and easier to use than traditional tests.
CLP’s Chris Wolski interviews Sara Naseri, MD, co-founder and CEO of Qvin, about a menstrual pad that collects blood for diagnostic purposes.
New studies have added at least six novel urine biomarkers of active renal lupus validated across two ethnically diverse patient cohorts
The measurement of six blood biomarkers improved the ability of researchers to predict a future increase in arterial inflammation.
Neurocode launched a blood test that can be used in the diagnosis of Alzheimer's disease based on circulating level of pTau217 in the blood.
A blood test could potentially be used to assess a patient’s risk of type 2 diabetes, a new study from Edith Cowan University has found.
The NIST released new standard reference material that uses urine to check for kidney disease and conditions that affect kidney function.
Diasorin received FDA 510(k) clearance for its new Liaison Plex platform and first panel of tests, the Liaison Plex Respiratory Flex Assay.
This method is faster than blood cultures and is less likely to generate false positives compared to other DNA detection-based technologies.